Skip to Content
Premium Article

Tech Phobia Buoys Fidelity Dividend Growth

Fidelity Dividend Growth Fund's manager's eschewal of tech pays off in late 2000, early 2001.


Fidelity Dividend Growth Fund (FDGFX) never caught tech fever, and that has kept shareholders' wallets a lot healthier.

If you know a fund's tech weight, you have a pretty good idea how it has performed over the past year. This tech-light offering has handily outpaced most of its rivals during that period. Manager Charles Mangum looks for stocks with reasonable valuations, and most tech stocks--particularly Internet-related issues--haven't met his criteria. Instead, Mangum has favored stocks in financials and health care, and that decision paid particularly big dividends toward the end of 2000. For example, last year Fannie Mae (FNM) and Eli Lilly (LLY) each surged 42%. Those stocks have taken breathers in early 2001, but they've still held up better than most tech issues. And within tech, Mangum's reasonably priced picks, including IBM (IBM), Microsoft (MSFT), and Dell Computer (DELL), have generally outperformed more-speculative fare during 2001's early going. For the year to date through March 6, 2001, the fund had lost 2.5%. That might not sound like much of a return, but it bettered more than four fifths of the fund's peers'.

This article is exclusive to Morningstar Premium members.

Start a 14-Day Free Trial

Scott Cooley does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.